Navigation Links
ADVENTRX Announces Public Offering of Stock
Date:11/10/2011

anned phase 3 clinical trials for ANX-188 and ANX-514 are not successful and, even if they are successful, that the FDA could determine they are not sufficient to support NDAs for ANX-188 and/or ANX-514 or, in the case of ANX-514, to eliminate corticosteroid premedication; the risk that the FDA does not grant market approval of ANX-188 and/or ANX-514 on a timely basis, or at all; ADVENTRX's reliance on third parties to assist in the conduct of important aspects of its product candidates' development programs, including the manufacture of clinical trial material, the conduct of clinical trials and regulatory submissions related to product approval, and that such third parties may fail to perform as expected; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov.  

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ST. LOUIS, July 29, 2014  Express Scripts Holding ... quarter net income attributable to Express Scripts stockholders of ... per diluted share, as detailed in Table 4, was ... "We are well positioned to serve our clients with ... and to improve the health outcomes of our members," stated ...
(Date:7/29/2014)... 29, 2014 Regado Biosciences, Inc. (Nasdaq: ... Phase 3 clinical development of Revolixys™ Kit (previously known ... today announced that it will hold a conference call ... at 8:30 a.m. EDT to discuss its second quarter ... participants and investors may access the conference call by ...
(Date:7/29/2014)... VIEW, Calif. , July 29, 2014  Alexza ... that it is participating in two healthcare conferences during ... Conference and the Morgan Stanley Global Healthcare 2014 Conference. ... Morgan Stanley Conference.  The details on each event are ... Conference, Monday, August 11, 2014 in Boston ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 18Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 19Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 20Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 21Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 22Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 23Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 24Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 26Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 27Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 28Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 29Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 30Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 31Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3
(Date:7/30/2014)... 30, 2014 Pain Free Living web: ... bracelet for pain relief and improved performance. This new ... embedded in a silicone core that is sheathed in ... and is embedded with scalar energy and Schumann frequency ... Free Living has 12 years experience developing magnetic bracelets. ...
(Date:7/29/2014)... 2014 Recently, iFitDress.com, a well-known wedding dress ... satin bridal gowns . Aside from this, it has announced ... to 68 percent off. All of its old and new ... company’s sales representative says excitedly, “We are pleased to release ... range, there are a lot of amazing items. It is ...
(Date:7/29/2014)... VogueQueen.com, a well-known online supplier, now allows worldwide clients ... fashion by providing graceful and sexy lingerie collection for ... of sexy dresses , designed and developed by ... take price into consideration. Worry no more, because VogueQueen.com ... affordable for all clients. , VogueQueen.com’s top designers ...
(Date:7/29/2014)... (Wednesday, July 30, 2014)A diet rich in soy may ... study published online today in Menopause , the ... soy consumption, similar to the diet of women in ... diet after menopause, similar to Asian migrants to North ... lifelong Western diet, and switching to soy from a ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... that the new method was created for any sufferer who ... problem. , The author of the new program, Sarah ... , Sarah actually suffered from yeast infection, too. Actually, this ... a cure for this problem. , The Natural ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:VogueQueen.com Now Provides Graceful And Sexy Lingerie Collection For August 2Health News:Soy may help women's hearts if they start early 2Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2
... (HealthDay News) -- When paramedics say a patient,s symptoms ... study suggests. Researchers at Loyola University Medical ... brought to the center,s emergency department by emergency medical ... patients with a 99.3 percent specificity. A high specificity ...
... , FRIDAY, March 30 (HealthDay News) -- Nearly ... some point in their lives, and these kids are bullied ... new survey finds. Bullying occurs in every grade but ... to 49 percent of autistic children in those grades bullied, ...
... Institute on Asian Consumer Insight (ACI) announced its strategy and ... to grow their business in Asia. Top on ... Financial Times. Modelled in format after the World Economic Forum ... leaders, will be a platform to examine Asian consumers. ...
... the public have already long suspected is now ... Ruhr-Universitt Bochum (RUB) and University of Basel: ADHD, ... showed that child and adolescent psychotherapists and psychiatrists ... unclear rules of thumb, rather than adhering to ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, March ... continues to rise among American children, with one in 88 ... Control and Prevention reported Thursday. That,s an increase from ... two years ago. The newer data, from 2008, also shows ...
... the United States has an autism spectrum disorder. The ... 29) that looked at data gathered in 2008 from 14 communities, ... that autism rates in the U.S. are higher than previous estimates ... with autism or a related disorder. The latest figures also show ...
Cached Medicine News:Health News:When Paramedics Suspect Stroke, They're Usually Right 2Health News:Two-Thirds of Kids With Autism Have Been Bullied: Study 2Health News:National institute launched to help businesses grow with Asian consumers 2Health News:National institute launched to help businesses grow with Asian consumers 3Health News:National institute launched to help businesses grow with Asian consumers 4Health News:National institute launched to help businesses grow with Asian consumers 5Health News:ADHD is over-diagnosed 2Health News:U.S. Autism Rate Rises to 1 in 88 Children, CDC Reports 2Health News:U.S. Autism Rate Rises to 1 in 88 Children, CDC Reports 3Health News:U.S. Autism Rate Rises to 1 in 88 Children, CDC Reports 4
... Prep Swabsticks are saturated with a 10% ... available iodine. Povidone Iodine is virtually non-irritating ... is also non-staining to the skin or ... microbes on contact; they are sturdy tools ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
... Swabsticks are packaged in easy open, single-use ... saturated with precisely the correct amount of ... the safest possible product for the patient. ... an excellent combination of ethyl alcohol and ...
Medicine Products: